HRP20120257T1 - Antagonisti receptora 5-ht7 - Google Patents

Antagonisti receptora 5-ht7 Download PDF

Info

Publication number
HRP20120257T1
HRP20120257T1 HR20120257T HRP20120257T HRP20120257T1 HR P20120257 T1 HRP20120257 T1 HR P20120257T1 HR 20120257 T HR20120257 T HR 20120257T HR P20120257 T HRP20120257 T HR P20120257T HR P20120257 T1 HRP20120257 T1 HR P20120257T1
Authority
HR
Croatia
Prior art keywords
hydrogen
methyl
compound according
compound
fluorine
Prior art date
Application number
HR20120257T
Other languages
English (en)
Croatian (hr)
Inventor
O. Badescu Valentina
Ann Filla Sandra
Thaddeus Gallagher Peter
Ann Whatton Maria
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20120257T1 publication Critical patent/HRP20120257T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20120257T 2007-10-12 2008-09-30 Antagonisti receptora 5-ht7 HRP20120257T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
HRP20120257T1 true HRP20120257T1 (hr) 2012-04-30

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120257T HRP20120257T1 (hr) 2007-10-12 2008-09-30 Antagonisti receptora 5-ht7

Country Status (19)

Country Link
US (1) US7910588B2 (enExample)
EP (1) EP2201002B1 (enExample)
JP (1) JP5291716B2 (enExample)
KR (1) KR101161070B1 (enExample)
CN (1) CN101821257B (enExample)
AT (1) ATE548365T1 (enExample)
AU (1) AU2008311154B2 (enExample)
BR (1) BRPI0818450A2 (enExample)
CA (1) CA2699674C (enExample)
CY (1) CY1112709T1 (enExample)
DK (1) DK2201002T3 (enExample)
EA (1) EA016787B1 (enExample)
ES (1) ES2380756T3 (enExample)
HR (1) HRP20120257T1 (enExample)
MX (1) MX2010003986A (enExample)
PL (1) PL2201002T3 (enExample)
PT (1) PT2201002E (enExample)
SI (1) SI2201002T1 (enExample)
WO (1) WO2009048765A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
KR20140075783A (ko) 2011-10-11 2014-06-19 유씨비 파마, 에스.에이. 2­옥소­피페리디닐 유도체
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
EP3200589A4 (en) 2014-09-10 2018-07-25 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
CA3043319A1 (en) 2016-11-15 2018-05-24 Temple University-Of The Commonwealth System Of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
JP7365238B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
WO2004067703A2 (en) * 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
AU2005249494A1 (en) 2004-05-28 2005-12-15 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
CN101821257A (zh) 2010-09-01
CN101821257B (zh) 2013-05-22
US20100197700A1 (en) 2010-08-05
CA2699674C (en) 2013-07-16
CY1112709T1 (el) 2016-02-10
EA201070462A1 (ru) 2010-10-29
EA016787B1 (ru) 2012-07-30
BRPI0818450A2 (pt) 2015-05-12
ES2380756T3 (es) 2012-05-18
KR101161070B1 (ko) 2012-07-13
EP2201002A1 (en) 2010-06-30
PT2201002E (pt) 2012-04-27
DK2201002T3 (da) 2012-04-10
WO2009048765A1 (en) 2009-04-16
ATE548365T1 (de) 2012-03-15
AU2008311154B2 (en) 2013-09-26
KR20100054853A (ko) 2010-05-25
PL2201002T3 (pl) 2012-07-31
MX2010003986A (es) 2010-04-27
EP2201002B1 (en) 2012-03-07
CA2699674A1 (en) 2009-04-16
JP5291716B2 (ja) 2013-09-18
AU2008311154A1 (en) 2009-04-16
US7910588B2 (en) 2011-03-22
JP2011500575A (ja) 2011-01-06
SI2201002T1 (sl) 2012-04-30

Similar Documents

Publication Publication Date Title
HRP20120257T1 (hr) Antagonisti receptora 5-ht7
EP4467549A3 (en) Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives
RU2009128966A (ru) Новые производные аминопиримидина в качестве ингибиторов plr1
HRP20180528T1 (hr) Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina
SE0202463D0 (sv) Novel compounds
HRP20210459T1 (hr) Supstituirani derivati oksopiridina
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NZ564696A (en) Glucocorticoid, indazole, mimetics, methods of making them, pharmaceutical compositions, and uses thereof
UA99617C2 (ru) Производные пирролконденсированного азотсодержащего гетероцикла, их получение и фармацевтическое применение
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
PH12021550687A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
CY1114803T1 (el) Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
SE0402762D0 (sv) Indazole sulphonamide derivatives
TW200508207A (en) New benzimidazole derivatives
NO20064705L (no) Nye farmasoytiske preparater omfattende agonister av tyroidreseptoren
AR080875A1 (es) Inhibidores de la actividad de la proteina tirosina quinasa
CY1111102T1 (el) 2-(4-κυανοφαινυλ)-6-υδροξυλαμινοπυριμιδινες που αναστελλουν τον hiv
HRP20110624T1 (hr) Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7
TW200531694A (en) Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
MY143578A (en) Piperazinediones as oxytocin receptor antagonists
HRP20110436T1 (hr) Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i
JP2011500575A5 (enExample)
MY152022A (en) A novel benzoxazine benzimidazole derivatives, a pharmaceutical composition comprising the same, and a use thereof
ATE388939T1 (de) N-((piperazinyl)hetaryl)arylsulfonamid-derivate mit affinität zum dopamin-d3-rezeptor